NATURE’S SUNSHINE PRODUCTS, INC. Net Income (Loss) Attributable to Noncontrolling Interest
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) reported Net Income (Loss) Attributable to Noncontrolling Interest of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2026-08-06
- NATURE’S SUNSHINE PRODUCTS, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-12-31 was $406.00K.
- NATURE’S SUNSHINE PRODUCTS, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-09-30 was $201.00K, a 32.78% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. net income (loss) attributable to noncontrolling interest for fiscal 2025 was $930.00K, a 374.49% increase from fiscal 2024.
- NATURE’S SUNSHINE PRODUCTS, INC. net income (loss) attributable to noncontrolling interest for fiscal 2024 was $196.00K, a 85.37% decline from fiscal 2023.
- NATURE’S SUNSHINE PRODUCTS, INC. net income (loss) attributable to noncontrolling interest for fiscal 2023 was $1.34M, a 42.55% increase from fiscal 2022.
- NATURE’S SUNSHINE PRODUCTS, INC. net income (loss) attributable to noncontrolling interest for fiscal 2022 was $940.00K, a 30.58% decline from fiscal 2021.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | $406.00K derived: sum of 3 quarters · filed 2026-08-06 | $607.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 | $406.00K derived: sum of 2 quarters · filed 2026-05-07 | $607.00K derived: sum of 3 quarters · filed 2026-05-07 | $793.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $406.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $607.00K derived: sum of 2 quarters · filed 2026-03-10 | $793.00K derived: sum of 3 quarters · filed 2026-08-06 | $930.00K 10-K · filed 2026-03-10 |
| 2025-09-30 | $201.00K 10-Q · filed 2025-11-06 | $387.00K derived: sum of 2 quarters · filed 2026-08-06 | $524.00K 10-Q · filed 2025-11-06 | $113.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $186.00K 10-Q · filed 2026-08-06 | $323.00K 10-Q · filed 2026-08-06 | -$88.00K derived: sum of 3 quarters · filed 2026-08-06 | $211.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $137.00K 10-Q · filed 2026-05-07 | -$274.00K derived: sum of 2 quarters · filed 2026-05-07 | $25.00K derived: sum of 3 quarters · filed 2026-05-07 | $164.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$411.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$112.00K derived: sum of 2 quarters · filed 2026-03-10 | $27.00K derived: sum of 3 quarters · filed 2026-03-10 | $196.00K 10-K · filed 2026-03-10 |
| 2024-09-30 | $299.00K 10-Q · filed 2025-11-06 | $438.00K derived: sum of 2 quarters · filed 2025-11-06 | $607.00K 10-Q · filed 2025-11-06 | $989.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $139.00K 10-Q · filed 2025-07-31 | $308.00K 10-Q · filed 2025-07-31 | $690.00K derived: sum of 3 quarters · filed 2025-07-31 | $1.00M derived: sum of 4 quarters · filed 2025-07-31 |
| 2024-03-31 | $169.00K 10-Q · filed 2025-05-06 | $551.00K derived: sum of 2 quarters · filed 2025-05-06 | $861.00K derived: sum of 3 quarters · filed 2025-05-06 | $1.12M derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | $382.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $692.00K derived: sum of 2 quarters · filed 2025-03-11 | $947.00K derived: sum of 3 quarters · filed 2025-03-11 | $1.34M 10-K · filed 2025-03-11 |
| 2023-09-30 | $310.00K 10-Q · filed 2024-11-07 | $565.00K derived: sum of 2 quarters · filed 2024-11-07 | $958.00K 10-Q · filed 2024-11-07 | $1.09M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $255.00K 10-Q · filed 2024-08-08 | $648.00K 10-Q · filed 2024-08-08 | $778.00K derived: sum of 3 quarters · filed 2024-08-08 | $888.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $393.00K 10-Q · filed 2024-05-07 | $523.00K derived: sum of 2 quarters · filed 2024-05-07 | $633.00K derived: sum of 3 quarters · filed 2024-05-07 | $1.07M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $130.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $240.00K derived: sum of 2 quarters · filed 2024-03-12 | $676.00K derived: sum of 3 quarters · filed 2024-03-12 | $940.00K 10-K · filed 2024-03-12 |
| 2022-09-30 | $110.00K 10-Q · filed 2023-11-07 | $546.00K derived: sum of 2 quarters · filed 2023-11-07 | $810.00K 10-Q · filed 2023-11-07 | $1.17M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $436.00K 10-Q · filed 2023-08-09 | $700.00K 10-Q · filed 2023-08-09 | $1.06M derived: sum of 3 quarters · filed 2023-08-09 | $1.66M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $264.00K 10-Q · filed 2023-05-09 | $628.00K derived: sum of 2 quarters · filed 2023-05-09 | $1.23M derived: sum of 3 quarters · filed 2023-05-09 | $1.48M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $364.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $964.00K derived: sum of 2 quarters · filed 2023-03-16 | $1.22M derived: sum of 3 quarters · filed 2023-03-16 | $1.35M 10-K · filed 2023-03-16 |
| 2021-09-30 | $600.00K 10-Q · filed 2022-11-03 | $854.00K derived: sum of 2 quarters · filed 2022-11-03 | $990.00K 10-Q · filed 2022-11-03 | $1.77M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $254.00K 10-Q · filed 2022-08-09 | $390.00K 10-Q · filed 2022-08-09 | $1.17M derived: sum of 3 quarters · filed 2022-08-09 | $1.59M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $136.00K 10-Q · filed 2022-05-05 | $920.00K derived: sum of 2 quarters · filed 2022-05-05 | $1.33M derived: sum of 3 quarters · filed 2022-05-05 | $1.71M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $784.00K 10-K · filed 2021-03-10 | $1.20M derived: sum of 2 quarters · filed 2021-11-04 | $1.58M derived: sum of 3 quarters · filed 2021-11-04 | $1.62M 10-K · filed 2022-03-08 |
| 2020-09-30 | $414.00K 10-Q · filed 2021-11-04 | $793.00K derived: sum of 2 quarters · filed 2021-11-04 | $837.00K 10-Q · filed 2021-11-04 | $1.05M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $379.00K 10-Q · filed 2021-08-05 | $423.00K 10-Q · filed 2021-08-05 | $641.00K derived: sum of 3 quarters · filed 2021-08-05 | $675.00K derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $44.00K 10-Q · filed 2021-05-06 | $262.00K derived: sum of 2 quarters · filed 2021-05-06 | $296.00K derived: sum of 3 quarters · filed 2021-05-06 | $236.00K derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | $218.00K 10-K · filed 2021-03-10 | $252.00K derived: sum of 2 quarters · filed 2021-03-10 | $192.00K derived: sum of 3 quarters · filed 2021-03-10 | $164.00K 10-K · filed 2021-03-10 |
| 2019-09-30 | $34.00K 10-K · filed 2021-03-10 | -$26.00K derived: sum of 2 quarters · filed 2021-03-10 | -$54.00K 10-Q · filed 2020-11-09 | $50.00K derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-06-30 | -$60.00K 10-K · filed 2021-03-10 | -$88.00K 10-Q · filed 2020-08-06 | $16.00K derived: sum of 3 quarters · filed 2021-03-10 | -$142.00K derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-03-31 | -$28.00K 10-K · filed 2021-03-10 | $76.00K derived: sum of 2 quarters · filed 2021-03-10 | -$82.00K derived: sum of 3 quarters · filed 2021-03-10 | -$211.00K derived: sum of 4 quarters · filed 2021-03-10 |
| 2018-12-31 | $104.00K 10-K · filed 2020-03-11 | -$54.00K derived: sum of 2 quarters · filed 2020-03-11 | -$183.00K derived: sum of 3 quarters · filed 2020-03-11 | -$348.00K 10-K · filed 2020-03-11 |
| 2018-09-30 | -$158.00K 10-K · filed 2020-03-11 | -$287.00K derived: sum of 2 quarters · filed 2020-03-11 | -$452.00K 10-Q · filed 2019-11-07 | -$702.00K derived: sum of 4 quarters · filed 2020-03-11 |
| 2018-06-30 | -$129.00K 10-K · filed 2020-03-11 | -$294.00K 10-Q · filed 2019-08-09 | -$544.00K derived: sum of 3 quarters · filed 2020-03-11 | -$639.00K derived: sum of 4 quarters · filed 2020-03-11 |
| 2018-03-31 | -$165.00K 10-K · filed 2020-03-11 | -$415.00K derived: sum of 2 quarters · filed 2020-03-11 | -$510.00K derived: sum of 3 quarters · filed 2020-03-11 | -$743.00K derived: sum of 4 quarters · filed 2020-03-11 |
| 2017-12-31 | -$250.00K 10-K · filed 2019-03-08 | -$345.00K derived: sum of 2 quarters · filed 2019-03-08 | -$578.00K derived: sum of 3 quarters · filed 2019-03-08 | -$875.00K 10-K · filed 2019-03-08 |
| 2017-09-30 | -$95.00K 10-K · filed 2019-03-08 | -$328.00K derived: sum of 2 quarters · filed 2019-03-08 | -$625.00K 10-Q · filed 2018-11-08 | -$1.39M derived: sum of 4 quarters · filed 2019-03-08 |
| 2017-06-30 | -$233.00K 10-K · filed 2019-03-08 | -$530.00K 10-Q · filed 2018-08-08 | -$1.30M derived: sum of 3 quarters · filed 2019-03-08 | -$1.51M derived: sum of 4 quarters · filed 2019-03-08 |
| 2017-03-31 | -$297.00K 10-K · filed 2019-03-08 | -$1.07M derived: sum of 2 quarters · filed 2019-03-08 | -$1.28M derived: sum of 3 quarters · filed 2019-03-08 | -$1.48M derived: sum of 4 quarters · filed 2019-03-08 |
| 2016-12-31 | -$769.00K 10-K · filed 2018-03-16 | -$982.00K derived: sum of 2 quarters · filed 2018-03-16 | -$1.18M derived: sum of 3 quarters · filed 2018-03-16 | -$1.46M 10-K · filed 2019-03-08 |
| 2016-09-30 | -$213.00K 10-K · filed 2018-03-16 | -$415.00K derived: sum of 2 quarters · filed 2018-03-16 | -$695.00K 10-Q · filed 2017-11-09 | -$1.05M derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-06-30 | -$202.00K 10-K · filed 2018-03-16 | -$482.00K 10-Q · filed 2017-08-09 | -$840.00K derived: sum of 3 quarters · filed 2018-03-16 | -$1.20M derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-03-31 | -$280.00K 10-K · filed 2018-03-16 | -$638.00K derived: sum of 2 quarters · filed 2018-03-16 | -$993.00K derived: sum of 3 quarters · filed 2018-03-16 | -$1.16M derived: sum of 4 quarters · filed 2018-03-16 |
| 2015-12-31 | -$358.00K 10-K · filed 2017-03-14 | -$713.00K derived: sum of 2 quarters · filed 2017-03-14 | -$879.00K derived: sum of 3 quarters · filed 2017-03-14 | -$1.03M 10-K · filed 2018-03-16 |
| 2015-09-30 | -$355.00K 10-K · filed 2017-03-14 | -$521.00K derived: sum of 2 quarters · filed 2017-03-14 | -$673.00K 10-Q · filed 2016-11-09 | -$866.00K derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-06-30 | -$166.00K 10-K · filed 2017-03-14 | -$318.00K 10-Q · filed 2016-08-09 | -$511.00K derived: sum of 3 quarters · filed 2017-03-14 | -$537.00K derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-03-31 | -$152.00K 10-K · filed 2017-03-14 | -$345.00K derived: sum of 2 quarters · filed 2017-03-14 | -$371.00K derived: sum of 3 quarters · filed 2017-03-14 | -$371.00K derived: sum of 4 quarters · filed 2017-03-14 |
| 2014-12-31 | -$193.00K 10-K · filed 2016-03-14 | -$219.00K derived: sum of 2 quarters · filed 2016-03-14 | -$219.00K derived: sum of 3 quarters · filed 2016-03-14 | -$219.00K 10-K · filed 2017-03-14 |
| 2014-09-30 | -$26.00K 10-K · filed 2016-03-14 | -$26.00K derived: sum of 2 quarters · filed 2016-03-14 | -$26.00K 10-Q · filed 2015-11-06 | |
| 2014-06-30 | $0.00 10-K · filed 2016-03-14 | $0.00 derived: sum of 2 quarters · filed 2016-03-14 | ||
| 2014-03-31 | $0.00 10-K · filed 2016-03-14 | |||
| 2013-12-31 | $0.00 10-K · filed 2016-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |